Besides Illinois and North Carolina, the Tennessee pharmacy has distributed the steroidinjection to nine more states: Alabama, Arkansas, California, Florida, Kentucky, Louisiana, Mississippi, New Mexico, and South Carolina.
On October 15, federal authorities said that another NECC steroidinjection, triamcinolone acetonide, might have caused a patient to acquire fungal meningitis, and they began contacting all 192 state facilities that received any NECC injectable products.